Derek Meisner
2020 - X4 Pharmaceuticals
In 2020, Derek Meisner earned a total compensation of $1.1M as General Counsel at X4 Pharmaceuticals.
Compensation breakdown
| Bonus | $67,500 |
|---|---|
| Non-Equity Incentive Plan | $162,400 |
| Salary | $400,000 |
| Stock Awards | $471,500 |
| Other | $11,964 |
| Total | $1,113,364 |
Meisner received $471.5K in stock awards, accounting for 42% of the total pay in 2020.
Meisner also received $67.5K in bonus, $162.4K in non-equity incentive plan, $400K in salary and $12K in other compensation.
Rankings
In 2020, Derek Meisner's compensation ranked 8,173rd out of 13,090 executives tracked by ExecPay. In other words, Meisner earned more than 37.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,173 out of 13,090 | 38th |
Division Manufacturing | 3,467 out of 5,621 | 38th |
Major group Chemicals And Allied Products | 1,399 out of 2,254 | 38th |
Industry group Drugs | 1,218 out of 1,954 | 38th |
Industry Biological Products, Except Diagnostic Substances | 286 out of 411 | 30th |
Source: SEC filing on April 20, 2021.
Meisner's colleagues
We found two more compensation records of executives who worked with Derek Meisner at X4 Pharmaceuticals in 2020.
News
Acumen Pharmaceuticals CEO Daniel O'Connell's 2023 pay jumps 48% to $3.9M
April 22, 2024
Acumen Pharmaceuticals CEO Daniel O'Connell's 2022 pay jumps 80% to $2.7M
April 27, 2023
X4 Pharmaceuticals CEO Paula Ragan's 2021 pay slips 15% to $2.1M
April 25, 2022
X4 Pharmaceuticals CEO Paula Ragan's 2020 pay rises 1% to $2.5M
April 20, 2021